Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Highly Accessed Review

Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2)

Norbert Lameire1*, John A Kellum2 and for the KDIGO AKI Guideline Work Group3

Author Affiliations

1 Ghent University Hospital, De Pintelaan 185, Ghent B9000, Belgium

2 The CRISMA Center, Department of Critical Care Medicine, 604 Scaife Hall, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA

3 KDIGO AKI Guideline Work Group: John A Kellum (Work Group Co-Chair), University of Pittsburgh, PA, USA; Norbert Lameire (Work Group Co-Chair), University of Ghent, Belgium; Peter Aspelin, Karolinska Institute, Sweden; Rashad S Barsoum, Cairo University, Egypt; Emmanuel A Burdmann, University of São Paulo, Brazil; Stuart L Goldstein, Cincinnati Children's Hospital Medical Center, OH, USA; Charles A Herzog, Hennepin County Medical Center, MN, USA; Michael Joannidis, Medical University Innsbruck, Austria; Andreas Kribben, University of Duisburg-Essen, Germany; Andrew S Levey, Tufts University, MA, USA; Alison M Macleod, University of Aberdeen, UK; Ravindra L Mehta, University of California, San Diego, CA, USA; Patrick T Murray, University College Dublin, Ireland; Saraladevi Naicker, University of the Witwatersrand, South Africa; Steven M Opal, Brown University, RI, USA; Franz Schaefer, Heidelberg University Hospital, Germany; Miet Schetz, University of Leuven, Belgium; and Shigehiko Uchino, Jikei University School of Medicine, Japan

For all author emails, please log on.

Critical Care 2013, 17:205  doi:10.1186/cc11455

Published: 4 February 2013

Abstract

Acute kidney injury (AKI) is a common and serious problem affecting millions and causing death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes completed the first ever international multidisciplinary clinical practice guideline for AKI. The guideline is based on evidence review and appraisal, and covers AKI definition, risk assessment, evaluation, prevention, and treatment. Two topics, contrast-induced AKI and management of renal replacement therapy, deserve special attention because of the frequency in which they are encountered and the availability of evidence. Recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the Grading of Recommendations Assessment, Development and Evaluation approach. Limitations of the evidence are discussed and a detailed rationale for each recommendation is provided. This review is an abridged version of the guideline and provides additional rationale and commentary for those recommendation statements that most directly impact the practice of critical care.